HESTERBIOPharmaceuticals
Hester Biosciences Ltd — Balance Sheet
₹1259.10
-4.49%
Hester Biosciences Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Ordinary Shares Number | 0.85 Cr | 0.85 Cr | 0.85 Cr | 0.85 Cr |
| Share Issued | 0.85 Cr | 0.85 Cr | 0.85 Cr | 0.85 Cr |
| Net Debt | 202.19 Cr | 226.69 Cr | 255.32 Cr | 198.01 Cr |
| Total Debt | 213.25 Cr | 244.38 Cr | 274.15 Cr | 228.17 Cr |
| Tangible Book Value | 307.60 Cr | 287.86 Cr | 276.79 Cr | 257.94 Cr |
| Invested Capital | 522.03 Cr | 530.79 Cr | 547.71 Cr | 482.27 Cr |
| Working Capital | 69.99 Cr | 109.14 Cr | 78.90 Cr | 97.87 Cr |
| Net Tangible Assets | 307.60 Cr | 287.86 Cr | 276.79 Cr | 257.94 Cr |
| Capital Lease Obligations | 5.47 Cr | 5.38 Cr | 6.17 Cr | 5.88 Cr |
| Common Stock Equity | 314.25 Cr | 291.79 Cr | 279.73 Cr | 259.99 Cr |
| Total Capitalization | 447.62 Cr | 473.88 Cr | 464.54 Cr | 424.36 Cr |
| Total Equity Gross Minority Interest | 326.66 Cr | 302.88 Cr | 288.55 Cr | 267.39 Cr |
| Minority Interest | 12.40 Cr | 11.08 Cr | 8.82 Cr | 7.41 Cr |
| Stockholders Equity | 314.25 Cr | 291.79 Cr | 279.73 Cr | 259.99 Cr |
| Other Equity Interest | 305.75 Cr | 283.29 Cr | 283.88 Cr | 251.48 Cr |
| Retained Earnings | 237.09 Cr | 215.09 Cr | 203.04 Cr | 184.81 Cr |
| Additional Paid In Capital | 17.51 Cr | 17.51 Cr | 17.51 Cr | 17.51 Cr |
| Capital Stock | 8.51 Cr | 8.51 Cr | 8.51 Cr | 8.51 Cr |
| Common Stock | 8.51 Cr | 8.51 Cr | 8.51 Cr | 8.51 Cr |
| Total Liabilities Net Minority Interest | 326.73 Cr | 359.47 Cr | 381.42 Cr | 294.77 Cr |
| Total Non Current Liabilities Net Minority Interest | 201.54 Cr | 254.00 Cr | 232.72 Cr | 197.87 Cr |
| Other Non Current Liabilities | 53.22 Cr | 53.67 Cr | 24.00 Cr | -10000.00 |
| Non Current Pension And Other Postretirement Benefit Plans | 2.75 Cr | 2.53 Cr | 1.93 Cr | 1.27 Cr |
| Non Current Accrued Expenses | 0.00 | 2.25 Cr | 0.00 | 0.00 |
| Non Current Deferred Revenue | 53.22 Cr | 53.67 Cr | 32.25 Cr | 19.71 Cr |
| Non Current Deferred Taxes Liabilities | 5.93 Cr | 7.41 Cr | 7.35 Cr | 6.51 Cr |
| Long Term Debt And Capital Lease Obligation | 138.84 Cr | 187.42 Cr | 190.48 Cr | 169.81 Cr |
| Long Term Capital Lease Obligation | 5.47 Cr | 5.34 Cr | 5.67 Cr | 5.44 Cr |
| Long Term Debt | 133.37 Cr | 182.09 Cr | 184.81 Cr | 164.37 Cr |
| Long Term Provisions | 2.75 Cr | 2.53 Cr | 1.72 Cr | 1.27 Cr |
| Current Liabilities | 125.18 Cr | 105.47 Cr | 148.70 Cr | 96.90 Cr |
| Other Current Liabilities | 3.23 Cr | 3.21 Cr | 3.22 Cr | 3.40 Cr |
| Current Deferred Taxes Liabilities | 4.02 Cr | 2.46 Cr | 3.40 Cr | 0.94 Cr |
| Current Debt And Capital Lease Obligation | 74.41 Cr | 56.96 Cr | 83.67 Cr | 58.35 Cr |
| Current Capital Lease Obligation | 0.00 | 0.04 Cr | 0.50 Cr | 0.44 Cr |
| Current Debt | 74.41 Cr | 56.91 Cr | 83.17 Cr | 57.91 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | 1.03 Cr | 0.76 Cr | 0.51 Cr | 0.28 Cr |
| Current Provisions | 1.03 Cr | 0.76 Cr | 0.44 Cr | 0.28 Cr |
| Payables | 41.37 Cr | 39.06 Cr | 48.39 Cr | 32.96 Cr |
| Other Payable | 11.57 Cr | 12.76 Cr | 17.92 Cr | 14.46 Cr |
| Dividends Payable | 0.38 Cr | 0.44 Cr | 0.49 Cr | 0.48 Cr |
| Total Tax Payable | 4.02 Cr | 2.46 Cr | 3.39 Cr | 0.94 Cr |
| Accounts Payable | 29.42 Cr | 25.86 Cr | 29.98 Cr | 18.02 Cr |
| Total Assets | 653.38 Cr | 662.35 Cr | 669.97 Cr | 562.16 Cr |
| Total Non Current Assets | 458.21 Cr | 447.73 Cr | 442.37 Cr | 367.40 Cr |
| Other Non Current Assets | 2.57 Cr | 10000.00 | -0.04 Cr | 0.04 Cr |
| Non Current Prepaid Assets | 4.94 Cr | 3.52 Cr | 3.61 Cr | 3.82 Cr |
| Investmentin Financial Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Available For Sale Securities | 39.63 Cr | 33.71 Cr | 69.22 Cr | 20.82 Cr |
| Long Term Equity Investment | 34.05 Cr | 29.93 Cr | 25.30 Cr | 21.24 Cr |
| Investmentsin Joint Venturesat Cost | 34.05 Cr | 29.93 Cr | 25.30 Cr | 21.24 Cr |
| Goodwill And Other Intangible Assets | 6.66 Cr | 3.93 Cr | 2.94 Cr | 2.04 Cr |
| Other Intangible Assets | 6.66 Cr | 3.93 Cr | 2.94 Cr | 2.04 Cr |
| Net PPE | 410.95 Cr | 409.61 Cr | 409.10 Cr | 337.39 Cr |
| Accumulated Depreciation | -156.10 Cr | -140.69 Cr | -125.34 Cr | -110.07 Cr |
| Gross PPE | 567.05 Cr | 550.30 Cr | 534.44 Cr | 447.46 Cr |
| Construction In Progress | 178.27 Cr | 170.14 Cr | 150.19 Cr | 100.58 Cr |
| Other Properties | 5.92 Cr | 5.79 Cr | 5.34 Cr | 4.91 Cr |
| Machinery Furniture Equipment | 214.05 Cr | 205.31 Cr | 205.88 Cr | 192.07 Cr |
| Buildings And Improvements | 155.18 Cr | 155.42 Cr | 159.39 Cr | 139.64 Cr |
| Land And Improvements | 13.64 Cr | 13.64 Cr | 13.64 Cr | 10.26 Cr |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Assets | 195.17 Cr | 214.62 Cr | 227.59 Cr | 194.76 Cr |
| Other Current Assets | 18.47 Cr | 20.46 Cr | 26.02 Cr | 0.10 Cr |
| Restricted Cash | 1.63 Cr | 3.00 Cr | 2.15 Cr | 0.93 Cr |
| Prepaid Assets | 30.77 Cr | 32.76 Cr | 35.22 Cr | 30.01 Cr |
| Inventory | 70.38 Cr | 75.58 Cr | 84.81 Cr | 75.38 Cr |
| Other Inventories | 5.33 Cr | 4.58 Cr | 3.27 Cr | 2.95 Cr |
| Finished Goods | 42.62 Cr | 46.93 Cr | 52.88 Cr | 48.21 Cr |
| Work In Process | 10.06 Cr | 12.60 Cr | 15.08 Cr | 14.78 Cr |
| Raw Materials | 12.37 Cr | 11.47 Cr | 13.58 Cr | 9.44 Cr |
| Other Receivables | 10.63 Cr | 9.71 Cr | 9.59 Cr | 7.84 Cr |
| Taxes Receivable | 2.04 Cr | 1.93 Cr | 2.39 Cr | — |
| Accounts Receivable | 73.18 Cr | 78.64 Cr | 79.63 Cr | 55.28 Cr |
| Allowance For Doubtful Accounts Receivable | -5.37 Cr | -0.90 Cr | -0.70 Cr | -0.52 Cr |
| Gross Accounts Receivable | 78.55 Cr | 79.55 Cr | 80.33 Cr | 55.80 Cr |
| Cash Cash Equivalents And Short Term Investments | 6.55 Cr | 12.99 Cr | 13.80 Cr | 25.22 Cr |
| Other Short Term Investments | 0.96 Cr | 0.69 Cr | 1.13 Cr | 0.95 Cr |
| Cash And Cash Equivalents | 5.59 Cr | 12.31 Cr | 12.67 Cr | 24.27 Cr |
| Cash Financial | 5.59 Cr | 12.31 Cr | 12.67 Cr | 24.27 Cr |
| Defined Pension Benefit | — | 0.00 | 0.00 | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Hester Biosciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.